Navigation Links
Gene Mutation Tied to Majority of Cases of Mental Retardation
Date:2/4/2009

Finding might lead to better diagnosis and drug treatments, study says

WEDNESDAY, Feb. 4 (HealthDay News) -- Children who have the most common form of mental retardation -- called nonsyndromic mental retardation -- appear to have a genetic mutation that may contribute to the condition, new research finds.

What's unusual about the mutation is that it occurs during development of the child and is not passed on by the child's parents, the researchers said.

"Nonsyndromic mental retardation is a very common problem -- it involves about 3 percent of the population," said lead researcher Dr. Jacques L. Michaud, of the Center of Excellence in Neuromics at the University of Montreal in Canada. "It is the most common mental handicap in children."

Children and adults who have nonsyndromic mental retardation have no physical abnormality, they look like any other child or adult, but they nonetheless have the condition, Michaud said.

"We have good reason to think genes are the cause of this syndrome," he said.

The findings were published in the Feb. 5 issue of the New England Journal of Medicine.

For the study, Michaud and his colleagues zeroed in on the SYNGAP1 gene -- which produces a protein critical for learning and memory -- in 94 patients with nonsyndromic mental retardation. The researchers identified mutations in the gene in three children.

These are new mutations, Michaud said. "Mutations you find in the kids, but you don't find in the parents," he said. "The mutation arises in the development of the kid."

The mutations involve the brain, especially those areas that affect the development, function and connection between neurons, Michaud said.

The researchers then looked for the same mutations in 142 people with autism, 143 people with schizophrenia and 190 healthy people. None of these people had the mutations associated with nonsyndromic mental retardation, the researchers said.

One important aspect of this finding is that it explains the origins of nonsyndromic mental retardation, Michaud said. "For a lot of families, not having an explanation makes it difficult to accept the condition. Having an explanation helps them to better accept the condition," he said.

The finding should also reassure parents that the condition isn't inherited, he said.

Michaud thinks the finding may lead to the development of new methods to teach children with nonsyndromic mental retardation. And a long-term goal is to develop medications that would help these children, in much the same way that ADHD can be treated with drugs, he said.

Dr. Randi Hagerman, a professor of pediatrics and medical director of the M.I.N.D. Institute at the University of California, Davis, thinks the finding is important, because it could lead to better diagnosis and possibly treatment of the condition.

"This is an important paper, because it represents about 3 percent of nonsyndromic mental retardation," Hagerman said. "This suggests that more screening for this mutation should be done in the workup of patients," he said.

More information

To learn more about mental retardation, visit the Nemours Foundation.



SOURCES: Jacques L. Michaud, M.D., Center of Excellence in Neuromics, University of Montreal, Quebec, Canada; Randi Hagerman, M.D., professor of pediatrics, and medical director, M.I.N.D. Institute, University of California, Davis; Feb. 5, 2009, New England Journal of Medicine


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. The Bachmann-Strauss Dystonia & Parkinson Foundation: New Study Identifies Gene Mutations as Cause of Dystonia in Amish-Mennonite Families
2. Gene mutations increase risk for aggressive prostate cancer
3. 60 Million Worldwide Carry Heart Disease Mutation
4. Scientists identify new congenital neutropenia syndrome and causative gene mutation
5. Gene Mutation Tied to Inherited Fatal Lung Disease
6. Yeast mimics severity of mutations leading to fatal childhood illness
7. Mutations common to cancer and developmental disorder examined in a novel disease model
8. UBC researchers discover gene mutation that causes eye cancer
9. Gene Mutation in Dalmatians Sheds Light on Kidney Stones in Humans
10. Gene Mutation May Cause Some Cases of Seasonal Affective Disorder
11. Risk of breast cancer mutations underestimated for Asian women, Stanford study shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... The National Business ... National Registry of Emergency Medical Technicians and welcomes this organization to ... Dr. Jan G. West, Ph.D. , CEO & Organizational Psychologist at NBRI. “This ...
(Date:4/26/2017)... ... 26, 2017 , ... RawTrition now brings you BioEnergy which is a powder ... , RawTrition is taking nutrients to the next level! The superfoods ... its raw form (unlike the synthetically made options that are on the market). , ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... an agile ecosystem and domain expertise for sponsors and CROs to speed ... trial supply management (RTSM) software platform. Bioclinica AGILE RTSM provides ...
(Date:4/25/2017)... CA (PRWEB) , ... April 25, 2017 , ... ... access, support, and collaboration, announces Mirroring360 Pro . This new addition to ... comprehensive collaboration experience for education and business. , Mirroring360 Pro enables educators, business ...
(Date:4/25/2017)... ... 2017 , ... A stressful work environment can hurt the physical and emotional ... performance in the workplace. The goal of Clearview Resolution Services has always been to ... Clearview Resolution Services will be shutting down the office early on Fridays. The Clearview ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 Global Surgical ... devices are tubes used to remove excess liquid and ... serum, pus, urine, bile or lymph. Surgical drains are ... surgery such as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic ... prophylactic post-surgery to prevent accumulation of fluid e.g. blood ...
(Date:4/19/2017)... SAN DIEGO , April 19, 2017 /PRNewswire/ ... ("Sorrento"), an antibody-centric, clinical-stage biopharmaceutical company developing new ... today announced the closing of its previously announced ... common stock at a public offering price of ... commissions and estimated offering expenses payable by Sorrento.  ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology: